-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

113.P1.53 113. Sickle Cell Disease, Sickle Cell Trait and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster I

Symposia: Sickle Cell Disease, Sickle Cell Trait and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 9, 2023: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Lydian A. de Ligt1,2,3*, Aafke E. Gaartman2,4*, Kadère Konté2,4*, Taco W. Kuijpers2,5*, Karin Fijnvandraat2,6*, Bart J. Biemond7, Robin van Bruggen2* and Erfan Nur, MD, PhD2,4

1Department of Pediatric Hematology, Emma Children's Hospital, Amsterdam University Medical Centers, Amsterdam, Netherlands
2Department of Blood Cell Research, Sanquin Research and Landsteiner Laboratory, Amsterdam, Netherlands
3Department of Hematology, Amsterdam University Medical Centers, Amsterdam, AL, Netherlands
4Department of Hematology, Amsterdam University Medical Centers, Amsterdam, Netherlands
5Pediatric Immunology, Emma Children's Hospital, Amsterdam University Medical Centers, Amsterdam, Netherlands
6University of Amsterdam, Amsterdam, Netherlands
7Department of Hematology, Amsterdam University Medical Centers, location University of Amsterdam, Amsterdam, Netherlands

Vinzon Ibanez1*, Kestis Vaitkus1*, Robert Molokie, MD2, Yogenthiran Saunthararajah, MD3 and Donald Lavelle1

1University of Illinois Chicago, Jesse Brown VA Medical Center, Chicago, IL
2Division of Hematology/Oncology, University of Illinois Chicago, Chicago, IL
3Cleveland Clinic Case Western Reserve Univ., Cleveland, OH

Mya Angela Arellano, BS1*, Donovan Alexander Argueta, PhD2, Yugal Goel, PhD2,3*, Natalie Garcia2* and Kalpna Gupta, PhD2,4

1Hematology/Oncology Division, Department of Medicine, University of California, Victorville, CA
2Hematology/Oncology Division, Department of Medicine, University of California, Irvine, CA
3Hematology/Oncology Division, Department of Medicine, University of California, Irvine, Orange, CA
4Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN

Marion Serra1*, Patricia Hermand, PhD2*, Romain Duval, PhD3*, Carine Lefevre, PhD2*, Jade Merrer4*, Fallou Leye5*, Mohammad Salma, PhD6*, Marine Aglave, PhD7*, William Vainchenker, MD, PhD8*, Caroline Le Van Kim, PhD9*, Slim Azouzi, PhD10,11,12* and Berengere Koehl, MD, PhD13,14*

1Inserm S1134, Paris, FRA
2Integrated Red Blood Cell Biology, Inserm U1134, Paris, FRA
3Centre National de Référence pour les Groupes Sanguins, Établissement Français du Sang (EFS) Ile-de-France, Université de Paris Cité, UMR_S1134, BIGR, Inserm, Paris, France
4Unité d'Epidémiologie Clinique, INSERM CIC 1426, AP-HP, Hôpital Robert Debré,, Paris, France
5Unité d'Epidémiologie Clinique, INSERM CIC 1426, AP-HP, Hôpital Robert Debré, Paris, France
6Institut De GénéTique MoléCulaire, Montpellier, FRA
7Gustave Roussy Cancer Campus, Villejuif, France
8INSERM UMR1287, Gustave Roussy, Paris-Saclay University, Villejuif, France
9Université Paris Cité and Université des Antilles, INSERM, Biologie intégrée du globule rouge, F-75015 Paris, France, Paris, France
10CNRGS, EFS, Paris, France
11Laboratoire d'Excellence GR-Ex, Paris, France
12Inserm U1134, Integrated Biology of Red Blood Cells, Université Paris Cité, Inserm, Paris, France
13Hematology Unit, Sickle Cell disease Center, Hôpital Robert Debré, APHP, Université Paris Cité, Paris, France
14Integrated Red Blood Cell Biology, Inserm U1134, Laboratory of Excellence GrEx, Paris, France

Katie Lien, PhD1*, Joanna Gemel, PhD2*, Eric C. Beyer, MD, PhD3* and Gabrielle Lapping-Carr, MD4

1The University of Chicago Pritzker School of Medicine, Chicago, IL
2University of Chicago, Chicago, IL
3Comer Children's Hospital, University of Chicago, Chicago, IL
4Section of Pediatric Hematology/Oncology, Department of Pediatrics, University of Chicago, Chicago, IL

Patrick Ellsworth, MD1,2, Izabela Pawlinski1*, Rachel Sielaty, BS1*, Anton Ilich, MD1*, Chatphatai Moonla, MD1*, Yuriy Prokopenko, MD1*, Dougald M. Monroe, PhD1, Rafal Pawlinski, PhD3 and Nigel S. Key, MD1,2

1UNC Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC
2Division of Hematology, University of North Carolina at Chapel Hill, Chapel Hill, NC
3UNC Blood Research Center, University of North Carolina, Chapel Hill, NC

Zoe Sekyonda, BS1*, Calvin Abonga, MS2*, Christopher A. Delianides, MS2*, Solomon Oshabaheebwa, MS1*, Jane A. Little, MD3, Michael A. Suster, PhD1*, Pedram Mohseni, PhD1,4* and Umut A. Gurkan, PhD1,5

1Case Western Reserve University, Cleveland, OH
2Department of Electrical, Computer, and Systems Engineering, Case Western Reserve University, Cleveland, OH
3Division of Hematology and UNC Blood Research Center, University of North Carolina, Chapel Hill, NC
4Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH
5Department of Mechanical and Aerospace Engineering, Case Western Reserve University, Shaker Heights, OH

Marissa J.M. Traets1*, Brigitte A. van Oirschot1*, Titine J.J. Ruiter1,2*, Charles Levine3*, Anita W. Rijneveld, M.D.4, Judith J.M. Jans2*, Minke A.E. Rab1,4*, Yu-Wei Chen5* and Richard van Wijk1

1Central Diagnostic Laboratory - Research, University Medical Center Utrecht, Utrecht, Netherlands
2Section Metabolic Diagnostics, Department of Genetics, University Medical Center Utrecht, Utrecht, Netherlands
3Pfizer Inc., San Francisco
4Department of Hematology, Erasmus University Medical Center, Rotterdam, Netherlands
5Pfizer Inc, South San Francisco, CA

Varsha Bhat1*, Alka A Potdar, PhD2*, Ashwin P Patel, MD, PhD, MPH3, Gregory Gibson1*, G. Karen Yu, PhD2* and Vivien A Sheehan, PhD3

1Center for Integrative Genomics, School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA
2Pfizer Inc, South San Francisco, CA
3Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA

Roopa Taranath, PhD*, Li Zhao, MD, PhD*, Gregory Bourne, PhD*, Ramesh R Bhatt, PhD*, Scott Plevy, MD*, David Y Liu, PhD and Ashok Bhandari, PhD*

Protagonist Therapeutics, Inc., Newark, CA

Aliya U. Zaidi, PhD1*, Xiufeng Gao, MD, MSc1*, Robert Goodrich, BSc1*, Marta Ferranti, MSc1*, Rasa Borhan, BSc1*, Ke Liu, PhD1*, Nnamdi Okeke, PharmD1*, Michael Tarasev, PhD, MBA1*, Mariama Kabore2*, Courtney D. Fitzhugh, MD3, Priya Sethu Chockalingam, PhD4* and Patrick C. Hines, MD, PhD1,5

1Functional Fluidics Inc., Detroit, MI
2National Institutes of Health, Bethesda, MD
3Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
4Beam Therapeutics, Cambridge, MA
5Department of Pediatrics, Wayne State University School of Medicine, Detroit, MI

Ziming Li1*, Omika Katoch, Ph.D2*, Ramakrishna Ungalara1* and Tirthadipa Pradhan-Sundd, PhD3

1University of Pittsburgh, Pittsburgh, PA
2Pittsburgh Heart, Lung and Blood Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA
3Versiti Blood Research Institute, Milwaukee, WI

Cristiane Maria de Souza, PhD1*, Sami Yokoo2*, Ana Carolina Lima Camargo, PhD3*, Romenia Ramos Domingues2*, Carolina Lanaro, BSc, PhD1*, Marina Dorigatti Borges, PhD1*, Renata Sesti-Costa, PhD1*, Sara Teresinha Olalla Saad, MD1, Adriana Franco Paes Leme, PhD2* and Fernando Ferreira Costa, MD, PhD4

1Hematology and Hemotherapy Center, University of Campinas - UNICAMP, Campinas, Brazil
2National Center for Research in Energy and Materials (CNPEM), Campinas, Brazil
3University of Campinas - UNICAMP, Campinas, Brazil
4Hematology and Transfusion Center, University of Campinas - UNICAMP, Campinas, Sao Paulo, Brazil

Rikesh K Dubey, PhD1,2, Omika Katoch, Ph.D2,3*, Enrico M Novelli, MD2 and Prithu Sundd, PhD1,2,4,5

1Versiti blood research Institute, Milwaukee, WI
2Pittsburgh Heart, Lung and Blood Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA
3Versiti Blood Research Centre, Milwaukee, WI
4Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA
5Medical College of Wisconsin, Division of Hematology and Oncology, Milwaukee, WI

John Paderi, PhD1*, Rikesh K Dubey, PhD2, Gabriel Njikang, PhD1* and Prithu Sundd, PhD2

1IHP Therapeutics, San Carlos, CA
2Pittsburgh Heart, Lung and Blood Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA

Grace Bechtel, BSc1*, Gabriella Sugerman1*, Alicia Chang, MD2, Manuel Rausch, PhD3* and Adam Bush, PhD1

1Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX
2Pediatric Hematology/Oncology, Dell Children’s Medical Center, Austin, TX
3Department of Aerospace Engineering and Engineering Mechanics, The University of Texas at Austin, Austin, TX

*signifies non-member of ASH